OSTEOPHIL BETA-TCP— 510(k) K102937

Name: FDA 510(k) clearance K102937
Creator: U.S. Food and Drug Administration
Published: 2010-12-27

Substantially Equivalent

Cytophil, Inc.

FDA 510(k) clearance K102937 for OSTEOPHIL BETA-TCP, Substantially Equivalent on 2010-12-27. Applicant: Cytophil, Inc.. Device class: 2.

Clearance details

Applicant: Cytophil, Inc.
Product code: Code MQV
Device class: Class 2
Regulation: 21 CFR 888.3045
Advisory panel: Orthopedic
Date received: 2010-10-04
Decision date: 2010-12-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: East Troy, WI, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code MQV

view all

K262230 — Mg OSTEOREVIVE; Mg OSTEOCRETE2026-09-11
K260364 — Device 300419 Strip2026-06-02
K252797 — JAZBI Resorbable Bone Void Filler2026-05-26
K261008 — Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip +7 more2026-04-24
K253524 — Adaptos®Fuse Bone Graft2026-02-17

More clearances from Cytophil, Inc.

view all

K150400 — Renu Gel2015-04-06
K121795 — CALCIUM HYDROXYLAPATITE VOCAL FOLD IMPLANT2013-02-22
K093871 — PERIOPHIL B-TCP2010-04-22
K092788 — PERIOPHIL BIPHASIC2009-12-18
K081815 — VOCALIS GEL2009-01-05

Adverse events under product code MQV

product code MQV

Death: 6
Injury: 435
Total: 441

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.